MONAS
FINANCIAL
Home
About
Research
Data
Pricing
Team
News
Analysis
Press
Contact
Legal
← News
Leerink Partners Maintains Market Perform on Amgen, Raises Price Target to $464
Analyst Ratings
AMGN
Nov 5
AI-curated analysis for informational purposes only — not investment advice.
Leerink Partners Maintains Market Perform on Amgen, Raises Price Target to $464
Read the full story at benzinga.com →